Literature DB >> 33840847

Conditions Favoring Increased COVID-19 Morbidity and Mortality: Their Common Denominator and its Early Treatment.

Eliot Shevel1.   

Abstract

The factors contributing to increased morbidity and mortality in SARS-CoV-2 infection are diverse, and include diabetes, obesity, Chronic Obstructive Pulmonary Disease (COPD), advanced age, and male sex. Although there is no obvious connection between these, they do have one common denominator-they all have a tendency towards lower urine pH, which may indicate a lower-than-normal tissue pH. Furthermore, it has been shown that lower pH has two important negative influences: 1) it enhances viral fusion via the endosomal route, thereby facilitating viral multiplication; and 2) it facilitates increased production of inflammatory cytokines, thereby exacerbating the cytokine storm. This paper discusses published literature on lower tissue/interstitial pH in those diseases/co-morbidities that are known risk factors of severe COVID-19, and hypothesize that small doses of baking soda could be a simple, cost-effective, and rapid method of reducing both morbidity and mortality in COVID-19 patients. Copyright 2021 by the Missouri State Medical Association.

Entities:  

Year:  2021        PMID: 33840847      PMCID: PMC8029622     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  30 in total

Review 1.  The effects of extracellular pH on immune function.

Authors:  A Lardner
Journal:  J Leukoc Biol       Date:  2001-04       Impact factor: 4.962

Review 2.  Role of electrostatic repulsion in controlling pH-dependent conformational changes of viral fusion proteins.

Authors:  Joseph S Harrison; Chelsea D Higgins; Matthew J O'Meara; Jayne F Koellhoffer; Brian A Kuhlman; Jonathan R Lai
Journal:  Structure       Date:  2013-07-02       Impact factor: 5.006

3.  Mechanism for higher urine pH in normal women compared with men.

Authors:  Elaine M Worcester; Kristin J Bergsland; Daniel L Gillen; Fredric L Coe
Journal:  Am J Physiol Renal Physiol       Date:  2017-12-20

4.  Metabolic basis for low urine pH in type 2 diabetes.

Authors:  Naim M Maalouf; Mary Ann Cameron; Orson W Moe; Khashayar Sakhaee
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-22       Impact factor: 8.237

5.  Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.

Authors:  Armando Luis Negri; Francisco Rodolfo Spivacow; Elisa Elena Del Valle; Mariano Forrester; Gabriela Rosende; Irene Pinduli
Journal:  Urol Res       Date:  2008-11-05

6.  Effect of BMI and urinary pH on urolithiasis and its composition.

Authors:  Qazi Najeeb; Imran Masood; Neeru Bhaskar; Harnam Kaur; Jasbir Singh; Rajesh Pandey; K S Sodhi; Suvarna Prasad; Sheikh Ishaq; Ruhi Mahajan
Journal:  Saudi J Kidney Dis Transpl       Date:  2013-01

Review 7.  Acid-base disorders in patients with chronic obstructive pulmonary disease: a pathophysiological review.

Authors:  Cosimo Marcello Bruno; Maria Valenti
Journal:  J Biomed Biotechnol       Date:  2012-02-01

Review 8.  The COVID-19 Cytokine Storm; What We Know So Far.

Authors:  Dina Ragab; Haitham Salah Eldin; Mohamed Taeimah; Rasha Khattab; Ramy Salem
Journal:  Front Immunol       Date:  2020-06-16       Impact factor: 7.561

Review 9.  Science review: extracellular acidosis and the immune response: clinical and physiologic implications.

Authors:  John A Kellum; Mingchen Song; Jinyou Li
Journal:  Crit Care       Date:  2004-06-16       Impact factor: 9.097

10.  Relationship between acid-base status and inflammation in the critically ill.

Authors:  Fernando G Zampieri; John A Kellum; Marcelo Park; Otavio T Ranzani; Hermes V Barbeiro; Heraldo P de Souza; Luiz Monteiro da Cruz Neto; Fabiano Pinheiro da Silva
Journal:  Crit Care       Date:  2014-07-17       Impact factor: 9.097

View more
  1 in total

1.  Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease.

Authors:  Emaan Madany; Derick Okwan-Duodu; Raisa Balbuena-Merle; Jeanne E Hendrickson; David R Gibb
Journal:  Front Med (Lausanne)       Date:  2021-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.